Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mirror, mirror: new study probes Self-Recognition in psychosis risk

NCT ID NCT04945278

Knowledge-focused Sponsor: University Hospital, Brest Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study uses a special two-way mirror device to see how teenagers and young adults at risk for psychosis recognize themselves versus others. Participants sit opposite a healthy volunteer and report who they see as lighting changes. The goal is to find differences in self-other perception that could signal early psychosis vulnerability.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help us understand how self-recognition differs in people at risk for psychosis, potentially guiding future therapies.
What could go wrong
This is a small, early observational study with only 34 participants. It does not test any treatment, so direct benefits are unlikely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 34 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2022

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 25 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria for patients: * Aged from 15 to 25 years * Subject meeting the Ultra High Risk criteria at CAARMS and / or SPI-A * Signature of the consent (participants and parents for minors) * Subject affiliated to the social security scheme or benefiting from such a scheme Inclusion criteria for healthy volunteers: * Aged from 15 to 25 years * Subject not familiar to the patient to whom it is matched * Signature of the consent (participants and parents for minors) * Subject affiliated to the social security scheme or benefiting from such a scheme Exclusion Criteria for both patients and healthy volunteers: * History of epilepsy and / or migraine (due to the epileptogenic potential of light stimuli) * Refusal of participation of the minor even if the legal representatives want the subject to participate in the study * Claustrophobia * Wearing glasses * Abnormal right and left visual acuity without contact lenses * Distinctive signs on the face which cannot be temporarily removed * Subject under legal protection (curators / guardianship) or deprived of liberty

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Psychosis of childhood borderline are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

psychotic disorder Psychotic Disorders Schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Psychosis of childhood borderline Psychotic disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHRU BREST Hôpital de Bohars

    RECRUITING

    Bohars, 29280, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.